---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "wu0PjJyopaWNwIZyVMwQSzKhUN6E/EAerjnh4YY3aWYwXPgLWfgJYOeetr1q92dJI3LzTXu1AnDy6M++ZSo1k5Gu24I32cI0RRbO1Q2/atDjeFq5uVvet/RDw3dWogpAWGZINhLKChp34LEmbn3yn/PkIrGQ+YqDhSGRwWqI7Jk0CBvmYgDeFTt2MeoyWDUXM3X6aM/8sQr4vkJMwEc1drEcq0ru9Mq/t2m3esFjqAdz6vWor0/jtFoDN5SQEBY78Dnw++CUaIauHnlmP6/Q8kXz9t5YnSnWtGHkN0c8oyB6Bkhv4bXU7jwRthpKd1kisAsWq0IqI/Wvg9SnOigiruoaiuxE0/MchqARC6vFcWM=;72KT3GszX5ySwSrZFgocnA=="
---

